We push the boundaries of science
AstraZeneca is one of only a handful of pure-play biopharmaceutical companies to span the entire value chain of a medicine from discovery, early- and late-stage development to manufacturing and distribution, and the global commercialization of primary care, specialty care-led and specialty care medicines that transform lives.
Our ultimate mission is to make a difference through our medicines for patients, their families, our stakeholders, and society in general. We believe that scientific research is the key to achieving this, in collaboration with others who share our interest and our passion. Within the overall AstraZeneca strategy, cutting-edge innovation is at the heart of what we do, and our R&D strategy has been carefully constructed to deliver on our promise to our patients, customers, and shareholders.
Young Health Program
The Young Health Program (YHP) is a global, long-term community investment initiative, aimed at improving the health of vulnerable young people around the world — now and into the future. In Canada, we aim to improve the mental and emotional well-being of disconnected and vulnerable youth ages 10 to 19. We cannot do this alone. So we have partnered with three leading Canadian organizations and are actively working with them to address this issue.